Matthew Mintz, M.D. Matthew Mintz, M.D.

Matthew Mintz, MD, FACP, is Associate Professor of Medicine and Director, Premier Access and Executive Services at The George Washington University School of Medicine in Washington, DC. Visit his blog at www.drmintz.com.

Doctors’ View Into the Future of Medicine: What Can Pharma Learn?

A Survey of America’s Physicians: Practice Patterns and Perspectives was recently completed on behalf ...

What the Industry Should Take Away from the Avandia Fiasco

GlaxoSmithKline’s Avandia (rosiglitazone) is an excellent drug. It is the only oral diabetes medication ...

Is DTC DOA?

Two things that I have noticed about direct-to-consumer (DTC) television advertisements lately is that ...

Physician POV: Getting Your Drug on Medication Guidelines

While some people may believe that pharma companies can just exert their financial power ...

What Pharma Should Do in 2013

At New Year’s resolution time, our physician expert offers five ways the industry can ...

The Role of Pharma in an ACO 

According to one of our physician columnists, the pharmaceutical industry should begin dealing with ...

Feeling a Doctor’s Pain When Pitching Products

Physicians and pharmaceutical reps face similar barriers regarding prescription medications. Commiserating and partnering could ...

It’s Time to Strengthen the Physician-Pharma Rep Link:

A recent study examines the unintended consequences for patients when doctors restrict their access ...

Let Your Representatives Represent

This past week, my Novo Nordisk representative dropped by to discuss Victoza. One of ...

You are Calling on the Wrong PCP

Though I have no pharmaceutical marketing or sales experience, I have spent enough time ...

Can Pharmaceutical Representatives Still Bring Value?

The availability of generic Lipitor marks the beginning of the end of the blockbuster ...